Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma.

Authors	Adrian Tempescul, Jean-Christophe Ianotto, Frederic Morel, Veronique Marion, Marc De Braekeleer, Christian Berthou
Journal	Annals of hematology (Ann Hematol) Vol. 88 Issue 9 Pg. 921-2 (Sep 2009) ISSN: 1432-0584 [Electronic] Germany
PMID	19139889 (Publication Type: Case Reports, Journal Article)
Chemical References	Antineoplastic Agents Thalidomide Lenalidomide
Topics	Aged Antineoplastic Agents (therapeutic use) Female Humans Lenalidomide Lymphoma, Mantle-Cell (drug therapy, genetics) Recurrence Remission Induction Thalidomide (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!